The association of tissue tumor mutational burden (tTMB) using the Foundation Medicine genomic platform with efficacy of pembrolizumab versus paclitaxel in patients (pts) with gastric cancer (GC) from KEYNOTE-061.

Aurora-Garg, Deepti; Lu, Jia; Shih, Chie-Schin; Adelberg, David; Cao, Z. Alexander; Fabrizio, David; Fuchs, Charles S.; Cristescu, Razvan; Kobie, Julie; Van Cutsem, Eric; Muro, Kei; Chung, Hyun Cheol; Olesinski, Tomasz; Vivaldi, Caterina; Ryu, Min-hee; Mandal, Mario; Di Bartolomeo, Maria; Bang, Yung-Jue; Ozguroglu, Mustafa; Shitara, Kohei

dc.contributor.author	Aurora-Garg, Deepti
dc.contributor.author	Lu, Jia
dc.contributor.author	Shih, Chie-Schin
dc.contributor.author	Adelberg, David
dc.contributor.author	Cao, Z. Alexander
dc.contributor.author	Fabrizio, David
dc.contributor.author	Fuchs, Charles S.
dc.contributor.author	Cristescu, Razvan
dc.contributor.author	Kobie, Julie
dc.contributor.author	Van Cutsem, Eric
dc.contributor.author	Muro, Kei
dc.contributor.author	Chung, Hyun Cheol
dc.contributor.author	Olesinski, Tomasz
dc.contributor.author	Vivaldi, Caterina
dc.contributor.author	Ryu, Min-hee
dc.contributor.author	Mandal, Mario
dc.contributor.author	Di Bartolomeo, Maria
dc.contributor.author	Bang, Yung-Jue
dc.contributor.author	Ozguroglu, Mustafa
dc.contributor.author	Shitara, Kohei
dc.date.accessioned	2021-03-02T18:31:38Z
dc.date.available	2021-03-02T18:31:38Z
dc.date.issued	2020
dc.identifier.citation	Shitara K., Ozguroglu M., Bang Y., Di Bartolomeo M., Mandal M., Ryu M., Vivaldi C., Olesinski T., Chung H. C. , Muro K., et al., "The association of tissue tumor mutational burden (tTMB) using the Foundation Medicine genomic platform with efficacy of pembrolizumab versus paclitaxel in patients (pts) with gastric cancer (GC) from KEYNOTE-061.", JOURNAL OF CLINICAL ONCOLOGY, cilt.38, 2020
dc.identifier.issn	0732-183X
dc.identifier.other	vv_1032021
dc.identifier.other	av_b86acb14-57d9-4cad-87db-fa4da9d41a6f
dc.identifier.uri	http://hdl.handle.net/20.500.12627/5105
dc.language.iso	eng
dc.subject	Dahili Tıp Bilimleri
dc.subject	Sağlık Bilimleri
dc.subject	Tıp
dc.subject	Klinik Tıp (MED)
dc.subject	Klinik Tıp
dc.subject	ONKOLOJİ
dc.subject	Onkoloji
dc.subject	İç Hastalıkları
dc.title	The association of tissue tumor mutational burden (tTMB) using the Foundation Medicine genomic platform with efficacy of pembrolizumab versus paclitaxel in patients (pts) with gastric cancer (GC) from KEYNOTE-061.
dc.type	Makale
dc.relation.journal	JOURNAL OF CLINICAL ONCOLOGY
dc.contributor.department	, ,
dc.identifier.volume	38
dc.identifier.issue	15
dc.contributor.firstauthorID	2281511

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Makale [92796]

Basit öğe kaydını göster